Member : Please login

Click here

How to subscribe

Click here

Not member yet ? Click here to register

Click here

News

26/11/2019 : Voxelotor
Click here

25/11/2019 : Cenobamate
Click here

21/11/2019 : Givosiran
Click here

18/11/2019 : Crizanlizumab
Click here

18/11/2019 : Cefiderocol
Click here

15/11/2019 : Zanubrutinib
Click here

11/11/2019 : Luspatercept
Click here

03/11/2019 : Diroximel fumarate
Click here

23/10/2019 : Elexacaftor + Tezacaftor + Ivacaftor
Click here

18/10/2019 : Lasmiditan
Click here

13/10/2019 : Levodopa (inhalation)
Click here
Click here

23/09/2019 : Semaglutide (oral)
Click here

07/09/2019 : Istradefylline
Click here

05/09/2019 : Lefamulin
Click here

04/09/2019 : Fedratinib
Click here

30/08/2019 : Entrectinib
Click here

29/08/2019 : Pretomanid
Click here

28/08/2019 : Upadacitinib
Click here

13/08/2019 : L-Arginine + L-Lysine
Click here

05/08/2019 : Pexidartinib
Click here

01/08/2019 : Darolutamide
Click here

19/07/2019 : imipenem + cilastatin + relebactam
Click here

19/07/2019 : Pentosan polysulfate sodium
Click here

Click here

05/07/2019 : Selinexor
Click here

24/06/2019 : Zanamivir IV
Click here

24/06/2019 : Bremelanotide
Click here

23/06/2019 : Polatuzumab vedotin
Click here

21/06/2019 : Ropeginterferon alfa-2b
Click here

21/06/2019 : Volanesorsen
Click here

21/06/2019 : Sotagliflozin
Click here

26/05/2019 : Alpelisib
Click here

29/04/2019 : Risankizumab
Click here

14/04/2019 : Erdafitinib
Click here

12/04/2019 : Romosozumab
Click here

29/03/2019 : Solriamfetol
Click here

29/03/2019 : Siponimod
Click here

28/03/2019 : Phendimetrazine tartrate
Click here

28/03/2019 : Testosterone undecanoate
Click here

23/03/2019 : Brexanolone
Click here

22/03/2019 : Curcuma longa
Click here

23/03/2019 : Macimorelin
Click here

20/03/2019 : Fexinidazole
Click here

15/03/2019 : Esketamine
Click here

05/03/2019 : Trastuzumab hyaluronidase
Click here

27/02/2019 :Turoctocog alfa pegol
Click here

Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience.
Tsai MC, et al. J Viral Hepat. 2019 Dec.
Click here

Contraception and CKD.
Burgner A, et al. CJASN. 2019 Nov.
Click here

Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.
Peerapornratana S,et al. Kidney Int. 2019 Nov.
Click here

Safe and Effective Management of Pain in People with CKD.
Davison SN, et al. CJASN 2019 Nov.
Click here

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA et al. Lancet. 2019 Oct 24.
Click here

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Neuen BL,et al. Lancet Diabetes Endocrinol. 2019 Nov.
Click here

Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Best LM, et al. Cochrane Database Syst Rev. 2019 Sep.
Click here

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE,et al. Ann Intern Med. 2019 Sep.
Click here

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Kristensen SL, et al. Lancet Diabetes Endocrinol. 2019 Oct.
Click here

Extracorporeal Removal of Poisons and Toxins.
King JD, et al. CJASN. 2019 Aug.
Click here

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Dave CV, et al. Ann Intern Med. 2019 Jul.
Click here

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
Wang Y, et al. JAMA Oncol. 2019 Jul.
Click here

Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Ha JT, et al. Ann Intern Med. 2019 Jul 16.
Click here

EASL Clinical Practice Guidelines: Drug-induced liver injury.
European Association for the Study of the Liver.  J Hepatol. 2019 Jun.
Click here

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors.
Centanni M, et al. Clin Pharmacokinet. 2019 Jul.
Click here

Sodium-glucose cotransporter inhibitors: beyond glycaemic control.
Vergara A,  et al. CKJ 2019 Jun.
Click here

Anticoagulant-related nephropathy: systematic review and meta-analysis.
de Aquino Moura KB, et al. CKJ 2019 Jun.
Click here

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, et al. NEJM 2019 Jul 4.
Click here

Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease
Sise ME, et al. Kidney Int. 2019 May 15.
Click here

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. NEJM. 2019 Jun 13.
Click here

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Mosenzon O, et al. Lancet Diabetes Endocrinol. 2019 Jun.
Click here

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
Charytan DM, et al. JACC 2019 Jun.
Click here

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
House AA, et al. Kidney Int. 2019 Jun.
Click here

Contrast-Associated Acute Kidney Injury.
Mehran R, et al. NEJM 2019 May 30.
Click here

Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
Vogt L, et al. JAHA 2019 May.
Click here

Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM, et al. JASN 2019 Apr.
Click here

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference.
Cheung AK, et al. for Conference Participants. Kidney Int. 2019 May.
Click here

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, et al. Lancet. 2019 Apr 20.
Click here

New pharmacological strategies for protecting kidney function in type 2 diabetes.
Muskiet MHA, et al. Lancet Diabetes Endocrinol. 2019 May.
Click here

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. for the CREDENCE Trial Investigators. NEJM 2019 Apr 14.
Click here

Clinical Pharmacology in Diuretic Use.
Ellison DH. CJASN 2019 Apr 1.
Click here

Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens SD, et al. Lancet Oncol. 2019 Apr.
Click here

The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
Rossignol P, et al. Kidney Int. 2019 Apr.
Click here

Management of Hypertension in Chronic Kidney Disease.
Dan Pugh, et al. Drugs 2019 Mar.
Click here

Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma.
Escudier B. NEJM 2019 Mar 21.
Click here

Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.
Vilay AM. ACKD. 2019 Jan.
Click here

Clinical Pharmacology of Antibiotics.
Eyler RF, et al. CJASN March 2019.
Click here

Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
Davison SN. Clin J Am Soc Nephrol. 2019 Mar 4.
Click here

Special Issue:Hepatitis C Virus Infection in Patients with Kidney Disease: A Roadmap for Nephrologists.
Semin Dial. 2019 Mar/Apr;32(2):89-197.
Click here

Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Lancet. 2019 Feb 23;3(10173):768-77.
Click here

Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.
Estrada CC, Maldonado A, Mallipattu SK. J Am Soc Nephrol. 2019 Feb;30(2):187-200.
Click here

Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. N Engl J Med. 2019 Feb 21;380(8):729-740.
Click here

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Sarafidis P, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230.
Click here

14/03/2019 : IPP et reins font-ils bon ménage ?
Click here

14/03/2019 : Hepatitis C Virus Infection in Patients with Chronic Kidney Disease
Click here

14/03/2019 : L'axe Reins - Microbiote
Click here

15/12/2018 : Insuffisance rénale et prescription - RenAdaptor
Click here

06/12/2018 : La grippe en 2018 - 2019
      Dr. Benoit Pirotte
      Click here

      Dr. Filip Moerman
       Click here

01/12/2018 : Nouveautés diagnostiques et thérapeutiques en néphrologie : Une décennie riche en avancées.
Click here

21/06/2018 : Propriétés néphroprotectrices des nouveaux anti-dabétiques oraux (ADO)
Click here

02/06/2018 : Anticoagulation et Insuffisance Rénale
Click here

18/04/2018 : Traitements de l'ostéoporose chez l'insuffisant rénal chronique.
Click here

08/03/2018 : Particularités pharmacologiques de la personne âgée
Click here

08/03/2018 : Cibles Cardio-Vasculaires chez les plus de 75 ans.
Click here

08/03/2018 : Polymédication chez la personne âgée
Click here

12/12/2017 : Polykystose Rénale Autosomique Dominante (PKRAD): Avancées thérapeutiques récentes
Click here

04/12/2017 : La prise en charge des patients séropositifs pour le VIH en 2017
Click here

25/11/2017 : Diagnostic et prévention de la lithiase rénale récidivante
Click here

09/03/2017 : Approche thérapeutique en oncologie: Le point de vue de l'oncologue.
Click here

09/03/2017 : Mélanome métastatique - Thérapies ciblées / Immunothérapies
Click here

09/03/2017 : Ajustement des traitements anticancéreux à l'insuffisance rénale - L'importance d'être précis
Click here

09/03/2017 : Toxicité rénale des traitements en oncologie: Focus sur les nouvelles thérapies
Click here

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Under the sponsorship of the Association of
French Speaking Nephrologists of Belgium (GNFB)